The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients-Reference-Cited by-同舟云学术

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients

Published:2009-09 Issue:3 Volume:4 Page:235-252
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Kelleher Muireann T.,Fruhwirth Gilbert,Patel Gargi,Ofo Enyinnaya,Festy Frederic,Barber Paul R.,Ameer-Beg Simon M.,Vojnovic Borivoj,Gillett Cheryl,Coolen Anthony,Kéri György,Ellis Paul A.,Ng Tony

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-009-0116-y.pdf

Reference99 articles.

1. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572

2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

3. Cole BF, Gelber RD, Gelber S et al (2001) Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 358:277–286

4. Early Breast Cancer Trialists' Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942

5. Rubens RD (1992) Management of early breast cancer. Bmj 304:1361–1364

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer;British Journal of Cancer;2022-11-09

2. Investigation of cancer drug resistance mechanisms by phosphoproteomics;Pharmacological Research;2020-10

3. HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial;JNCI: Journal of the National Cancer Institute;2019-12-18

4. Implementation and application of FRET–FLIM technology;Journal of Innovative Optical Health Sciences;2019-09

5. Fast single-cell biochemistry: theory, open source microscopy and applications;Methods and Applications in Fluorescence;2019-08-29